Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of unresectable or metastatic skin squamous cell cancer - Trial in progress
Academic Article
Publication Date:
2015
CRIS type:
1.1 Articolo in rivista
List of contributors:
Palla, M; Favales, F; Licitra, L; Ascierto, P; Bossi, P
Published in: